CompoAtlas

CALCIUM CARBONATE

Natural health product licensed in Canada

Other names
CALCIUM CARBONATE 500 mg
Licence holder
Les Emballages Façoteck
NPN or DIN-HM
80089460
Status
Active licence
Licence date
6 December 2018
Revision date
4 January 2019
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Calcium

Source : Calcium carbonate

200 milligrammeNot calculated

Non-medicinal ingredients

Croscarmellose de sodium, Poly(éthylène glycol), Povidone K-30, Dioxyde de titane, Stéarate de magnésium, Dioxyde de silicium, Talc, Hypromellose, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
Adultes et adolescentsNot specifiedminimum: 1 Comprimé ; maximum: 2 Comprimé1 Tous les jours

Uses authorised in Canada

Contribue au maintien d'une bonne santé. Aide au développement et au maintien des os et des dents surtout chez les enfants, les adolescents et les jeunes adultes. Un apport suffisant en calcium {et en vitamine D) {durant toute la durée de la vie) dans le cadre d'une alimentation saine {combine a la pratique régulière d'une activité physique) peut aider a prévenir la perte osseuse/l'ostéoporose {chez les femmes durant et après la ménopause) (plus tard dans la vie). Aide au développement et au maintien des os et des dents. Un apport suffisant en calcium (et en vitamine D) (durant toute la durée de la vie) dans le cadre d'une alimentation saine (combine a la pratique régulière d'une activité physique) peut réduire le risque de développer l'ostéoporose (chez les femmes durant et après la ménopause) (plus tard dans la vie).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80089460

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line